Overview
George Shubinsky practices in Beersheba, Israel. Mr. Shubinsky is rated as an Advanced expert by MediFind in the treatment of ZAP70-Related Severe Combined Immunodeficiency. His top areas of expertise are Hypoparathyroidism-Intellectual Disability-Dysmorphism Syndrome, ZAP70-Related Severe Combined Immunodeficiency, Trichorrhexis Nodosa, and Trichohepatoenteric Syndrome.
His clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of ZAP70-Related Severe Combined Immunodeficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Hypoparathyroidism-Intellectual Disability-Dysmorphism Syndrome
- ZAP70-Related Severe Combined Immunodeficiency
- Experienced
- Autoimmune Hemolytic AnemiaMr. Shubinsky isExperienced. Learn about Autoimmune Hemolytic Anemia.
- Autosomal Dominant Hyper IgE SyndromeMr. Shubinsky isExperienced. Learn about Autosomal Dominant Hyper IgE Syndrome.
- Familial Adenomatous PolyposisMr. Shubinsky isExperienced. Learn about Familial Adenomatous Polyposis.
- Hemolytic AnemiaMr. Shubinsky isExperienced. Learn about Hemolytic Anemia.
- Hyper IgE SyndromeMr. Shubinsky isExperienced. Learn about Hyper IgE Syndrome.
- Immunodeficiency with Hyper IgM Type 1Mr. Shubinsky isExperienced. Learn about Immunodeficiency with Hyper IgM Type 1.